Article info
PDFOriginal article
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus
- Correspondence to Silvia Lucangioli, Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Junin 956, Buenos Aires, Buenos Aires 1113, Argentina; slucangi{at}ffyb.uba.ar
Citation
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus
Publication history
- Received August 3, 2015
- Revised October 26, 2015
- Accepted November 11, 2015
- First published December 16, 2015.
Online issue publication
May 01, 2020
Article Versions
- Previous version (27 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/